Nasdaq - Delayed Quote USD

VALIC Company I - Health Sciences Fund (VCHSX)

14.81 -10.49 (-41.46%)
At close: May 11 at 8:01 PM EDT

Fund Summary

The fund normally invests at least 80% of its net assets in the common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences (collectively termed "health sciences"). While the fund can invest in companies of any size, the majority of fund assets are expected to be invested in large- and mid-cap companies. The fund may invest up to 35% of its total assets in foreign stocks, which include non-dollar denominated securities traded outside the U.S.

VALIC Company I - Health Sciences Fund

AIG Retirement CO I
2929 Allen Parkway A8-10
800-448-2542

Fund Overview

Category Health
Fund Family VALIC
Net Assets 966.13M
YTD Return -0.22%
Yield 0.00%
Morningstar Rating
Inception Date Nov 01, 2000

Fund Operations

Last Dividend 0.00
Last Cap Gain 0.00
Holdings Turnover 37.00%
Average for Category --

Fees & Expenses

Expense VCHSX Category Average
Annual Report Expense Ratio (net) 1.05% 1.03%
Prospectus Net Expense Ratio 1.05% --
Prospectus Gross Expense Ratio 1.09% --
Max 12b1 Fee -- --
Max Front End Sales Load -- 5.37%
Max Deferred Sales Load -- 1.19%
3 Yr Expense Projection 343 --
5 Yr Expense Projection 597 --
10 Yr Expense Projection 1,325 --

Management Information

Ziad Bakri, Lead Manager since April 01, 2016
Ziad Bakri joined T. Rowe Price in 2011 and has since been a key member of the healthcare research team, influencing investment decisions and making significant contributions to the stock selections. Ziad has had a long track record of analyzing biotechnology companies, a key sector within the healthcare industry. Ziad brings a unique perspective to his new role, having been a medical doctor and an emergency medicine resident at the Royal London Hospital before beginning his investment career. Prior to joining T. Rowe Price, Ziad held biotechnology equity research and healthcare investment ban

Morningstar Style Box

Yahoo partners with Morningstar a leading market research and investment data group to help investors rate and compare funds on Yahoo Finance. The Morningstar Category is shown next to the Morningstar Style Box which identifies a fund's investment focus, based on the underlying securities in the fund. MORNING_STAR_STYLE_BOX

Morningstar Category

While the investment objective stated in a fund's prospectus may or may not reflect how the fund actually invests, the Morningstar category is assigned based on the underlying securities in each portfolio. Morningstar categories help investors and investment professionals make meaningful comparisons between funds. The categories make it easier to build well-diversified portfolios, assess potential risk, and identify top-performing funds. We place funds in a given category based on their portfolio statistics and compositions over the past three years. If the fund is new and has no portfolio history, we estimate where it will fall before giving it a more permanent category assignment. When necessary, we may change a category assignment based on recent changes to the portfolio.

Related Tickers